Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 93% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer Kotak CRISIL-IBX Financial Services 3-6 Months Debt Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
4.1 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.50% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
93% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 36.9% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
27 Sept 2024 – open
Trough 4 Mar 2025 · not recovered
-18.2%
1 Dec 2022 – 26 May 2023
Trough 28 Mar 2023 · recovered in 59 days
-7.4%
18 Sept 2023 – 16 Nov 2023
Trough 26 Oct 2023 · recovered in 21 days
-5.0%
7 Mar 2024 – 23 May 2024
Trough 19 Apr 2024 · recovered in 34 days
-4.0%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
65
Vs category
17
Consistency
75
Risk-adjusted
47
Drawdown
54
Mean
52
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 32 holdings · top 10 are 36.9%.
ICICI Bank Ltd
Financial
3.9%
Sun Pharmaceutical Industries Ltd
Healthcare
3.8%
Apollo Hospitals Enterprise Ltd
Healthcare
3.8%
NTPC Ltd
Energy & Utilities
3.8%
Britannia Industries Ltd
Consumer Staples
3.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Kotak Mahindra Mutual Fund
Caveat: Lower trailing returns
ICICI Prudential Mutual Fund
Caveat: Higher volatility · Deeper drawdown
ICICI Prudential Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Kotak Mahindra Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Nippon India Mutual Fund
Caveat: Higher volatility · Lower trailing returns
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 93% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer Kotak CRISIL-IBX Financial Services 3-6 Months Debt Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
4.1 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.50% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
93% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 36.9% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · -9.2% over 1Y
14.9035
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-11.8%
27 Sept 2024 – open
Trough 4 Mar 2025 · not recovered
-18.2%
1 Dec 2022 – 26 May 2023
Trough 28 Mar 2023 · recovered in 59 days
-7.4%
18 Sept 2023 – 16 Nov 2023
Trough 26 Oct 2023 · recovered in 21 days
-5.0%
7 Mar 2024 – 23 May 2024
Trough 19 Apr 2024 · recovered in 34 days
-4.0%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
65
Vs category
17
Consistency
75
Risk-adjusted
47
Drawdown
54
Mean
52
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 32 holdings · top 10 are 36.9%.
ICICI Bank Ltd
Financial
3.9%
Sun Pharmaceutical Industries Ltd
Healthcare
3.8%
Apollo Hospitals Enterprise Ltd
Healthcare
3.8%
NTPC Ltd
Energy & Utilities
3.8%
Britannia Industries Ltd
Consumer Staples
3.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026